25 XP   0   0   10

Pharmaxis Ltd
Buy, Hold or Sell?

Let's analyse Pharmaxis together

PenkeI guess you are interested in Pharmaxis Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pharmaxis Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pharmaxis Ltd

I send you an email if I find something interesting about Pharmaxis Ltd.

Quick analysis of Pharmaxis (30 sec.)










What can you expect buying and holding a share of Pharmaxis? (30 sec.)

How much money do you get?

How much money do you get?
A$0.01
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.01
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.01
Return On Investment
26.4%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0.016 - A$0.027
How sure are you?
50%

1. Valuation of Pharmaxis (5 min.)




Live pricePrice per Share (EOD)

A$0.02

Intrinsic Value Per Share

A$-0.27 - A$0.10

Total Value Per Share

A$-0.25 - A$0.12

2. Growth of Pharmaxis (5 min.)




Is Pharmaxis growing?

Current yearPrevious yearGrowGrow %
How rich?$6.2m$7m-$812.1k-13.0%

How much money is Pharmaxis making?

Current yearPrevious yearGrowGrow %
Making money-$7.4m-$1.2m-$6.1m-83.0%
Net Profit Margin-197.1%-26.1%--

How much money comes from the company's main activities?

3. Financial Health of Pharmaxis (5 min.)




What can you expect buying and holding a share of Pharmaxis? (5 min.)

Welcome investor! Pharmaxis's management wants to use your money to grow the business. In return you get a share of Pharmaxis.

What can you expect buying and holding a share of Pharmaxis?

First you should know what it really means to hold a share of Pharmaxis. And how you can make/lose money.

Speculation

The Price per Share of Pharmaxis is A$0.021. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmaxis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmaxis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmaxis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-48.8%-0.01-48.8%0.00-8.3%-0.01-43.2%-0.01-48.1%
Usd Book Value Change Per Share0.00-5.4%0.00-5.4%0.0134.2%0.00-1.3%-0.01-25.1%
Usd Dividend Per Share0.009.7%0.009.7%0.0010.2%0.006.0%0.003.0%
Usd Total Gains Per Share0.004.3%0.004.3%0.0144.4%0.004.6%0.00-22.1%
Usd Price Per Share0.03-0.03-0.04-0.07-0.11-
Price to Earnings Ratio-3.12--3.12--24.34--12.34--4.02-
Price-to-Total Gains Ratio35.34-35.34-4.54-20.69-11.84-
Price to Book Ratio3.70-3.70-4.35-15.28-16.37-
Price-to-Total Gains Ratio35.34-35.34-4.54-20.69-11.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0136983
Number of shares73001
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (73001 shares)66.0370.80
Gains per Year (73001 shares)264.12283.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1592-328254365-82273
21185-656518731-164556
31777-9857821096-247839
42369-131310461462-3291122
52961-164113101827-4111405
63554-196915742192-4931688
74146-229718382558-5751971
84738-262521022923-6582254
95331-295423663289-7402537
105923-328226303654-8222820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%2.018.02.09.1%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%12.010.00.054.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%3.00.02.060.0%3.00.07.030.0%3.00.019.013.6%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%6.04.00.060.0%13.09.00.059.1%

Fundamentals of Pharmaxis

About Pharmaxis Ltd

Syntara Limited operates as a clinical stage drug development company that focuses on blood-related cancers. Its lead product candidate is PXS-5505, which is in phase 2 trial for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue leading to loss of red and white blood cells and platelets. The company was formerly known as Pharmaxis Ltd and changed its name to Syntara Limited in December 2023. Syntara Limited was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.

Fundamental data was last updated by Penke on 2024-03-18 11:47:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pharmaxis Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pharmaxis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pharmaxis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -197.1% means that $-1.97 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharmaxis Ltd:

  • The MRQ is -197.1%. The company is making a huge loss. -2
  • The TTM is -197.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-197.1%TTM-197.1%0.0%
TTM-197.1%YOY-26.1%-171.0%
TTM-197.1%5Y-164.7%-32.3%
5Y-164.7%10Y-198.5%+33.8%
1.1.2. Return on Assets

Shows how efficient Pharmaxis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharmaxis to the Drug Manufacturers - Specialty & Generic industry mean.
  • -47.3% Return on Assets means that Pharmaxis generated $-0.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharmaxis Ltd:

  • The MRQ is -47.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -47.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-47.3%TTM-47.3%0.0%
TTM-47.3%YOY-7.7%-39.6%
TTM-47.3%5Y-28.3%-18.9%
5Y-28.3%10Y-25.0%-3.4%
1.1.3. Return on Equity

Shows how efficient Pharmaxis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharmaxis to the Drug Manufacturers - Specialty & Generic industry mean.
  • -118.8% Return on Equity means Pharmaxis generated $-1.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharmaxis Ltd:

  • The MRQ is -118.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -118.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-118.8%TTM-118.8%0.0%
TTM-118.8%YOY-17.9%-100.9%
TTM-118.8%5Y-270.5%+151.7%
5Y-270.5%10Y-213.0%-57.5%

1.2. Operating Efficiency of Pharmaxis Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharmaxis is operating .

  • Measures how much profit Pharmaxis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharmaxis to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -193.2% means the company generated $-1.93  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharmaxis Ltd:

  • The MRQ is -193.2%. The company is operating very inefficient. -2
  • The TTM is -193.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-193.2%TTM-193.2%0.0%
TTM-193.2%YOY-207.3%+14.1%
TTM-193.2%5Y-218.8%+25.6%
5Y-218.8%10Y-211.8%-7.0%
1.2.2. Operating Ratio

Measures how efficient Pharmaxis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 5.39 means that the operating costs are $5.39 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pharmaxis Ltd:

  • The MRQ is 5.386. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.386. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.386TTM5.3860.000
TTM5.386YOY5.406-0.020
TTM5.3865Y5.348+0.039
5Y5.34810Y4.990+0.357

1.3. Liquidity of Pharmaxis Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharmaxis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.33 means the company has $2.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharmaxis Ltd:

  • The MRQ is 2.325. The company is able to pay all its short-term debts. +1
  • The TTM is 2.325. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.325TTM2.3250.000
TTM2.325YOY3.153-0.828
TTM2.3255Y3.456-1.130
5Y3.45610Y4.107-0.652
1.3.2. Quick Ratio

Measures if Pharmaxis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharmaxis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.42 means the company can pay off $2.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharmaxis Ltd:

  • The MRQ is 2.424. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.424. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.424TTM2.4240.000
TTM2.424YOY3.701-1.277
TTM2.4245Y4.596-2.172
5Y4.59610Y5.032-0.436

1.4. Solvency of Pharmaxis Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharmaxis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharmaxis to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.60 means that Pharmaxis assets are financed with 60.2% credit (debt) and the remaining percentage (100% - 60.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pharmaxis Ltd:

  • The MRQ is 0.602. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.602. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.602TTM0.6020.000
TTM0.602YOY0.571+0.031
TTM0.6025Y0.753-0.151
5Y0.75310Y0.744+0.010
1.4.2. Debt to Equity Ratio

Measures if Pharmaxis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharmaxis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 151.3% means that company has $1.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharmaxis Ltd:

  • The MRQ is 1.513. The company is just able to pay all its debts with equity.
  • The TTM is 1.513. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.513TTM1.5130.000
TTM1.513YOY1.331+0.182
TTM1.5135Y7.991-6.478
5Y7.99110Y6.147+1.844

2. Market Valuation of Pharmaxis Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pharmaxis generates.

  • Above 15 is considered overpriced but always compare Pharmaxis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -3.12 means the investor is paying $-3.12 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharmaxis Ltd:

  • The EOD is -1.336. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.117. Based on the earnings, the company is expensive. -2
  • The TTM is -3.117. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.336MRQ-3.117+1.781
MRQ-3.117TTM-3.1170.000
TTM-3.117YOY-24.337+21.220
TTM-3.1175Y-12.343+9.226
5Y-12.34310Y-4.022-8.321
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharmaxis Ltd:

  • The EOD is -2.047. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.775. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.775. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.047MRQ-4.775+2.729
MRQ-4.775TTM-4.7750.000
TTM-4.775YOY-2.828-1.947
TTM-4.7755Y-34.472+29.697
5Y-34.47210Y-17.194-17.278
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pharmaxis is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Pharmaxis Ltd:

  • The EOD is 1.587. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.704. Based on the equity, the company is fair priced.
  • The TTM is 3.704. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.587MRQ3.704-2.117
MRQ3.704TTM3.7040.000
TTM3.704YOY4.347-0.643
TTM3.7045Y15.285-11.581
5Y15.28510Y16.370-1.085
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pharmaxis Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pharmaxis Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.0020%0.011-116%0.000-75%-0.008+369%
Book Value Per Share--0.0130.0130%0.015-12%0.011+21%0.018-26%
Current Ratio--2.3252.3250%3.153-26%3.456-33%4.107-43%
Debt To Asset Ratio--0.6020.6020%0.571+5%0.753-20%0.744-19%
Debt To Equity Ratio--1.5131.5130%1.331+14%7.991-81%6.147-75%
Dividend Per Share--0.0030.0030%0.003-6%0.002+62%0.001+224%
Eps---0.016-0.0160%-0.003-83%-0.014-12%-0.015-1%
Free Cash Flow Per Share---0.010-0.0100%-0.023+124%-0.010-2%-0.009-17%
Free Cash Flow To Equity Per Share---0.001-0.0010%-0.014+2188%-0.001+37%-0.005+733%
Gross Profit Margin--1.0271.0270%1.390-26%1.213-15%1.109-7%
Intrinsic Value_10Y_max--0.104--------
Intrinsic Value_10Y_min---0.266--------
Intrinsic Value_1Y_max---0.004--------
Intrinsic Value_1Y_min---0.014--------
Intrinsic Value_3Y_max---0.002--------
Intrinsic Value_3Y_min---0.054--------
Intrinsic Value_5Y_max--0.014--------
Intrinsic Value_5Y_min---0.105--------
Market Cap15174894.336-133%35408086.78435408086.7840%46969911.040-25%75729948.877-53%117424777.600-70%
Net Profit Margin---1.971-1.9710%-0.261-87%-1.647-16%-1.985+1%
Operating Margin---1.932-1.9320%-2.073+7%-2.188+13%-2.118+10%
Operating Ratio--5.3865.3860%5.4060%5.348+1%4.990+8%
Pb Ratio1.587-133%3.7043.7040%4.347-15%15.285-76%16.370-77%
Pe Ratio-1.336+57%-3.117-3.1170%-24.337+681%-12.343+296%-4.022+29%
Price Per Share0.021-133%0.0490.0490%0.065-25%0.105-53%0.163-70%
Price To Free Cash Flow Ratio-2.047+57%-4.775-4.7750%-2.828-41%-34.472+622%-17.194+260%
Price To Total Gains Ratio15.145-133%35.33735.3370%4.543+678%20.693+71%11.836+199%
Quick Ratio--2.4242.4240%3.701-35%4.596-47%5.032-52%
Return On Assets---0.473-0.4730%-0.077-84%-0.283-40%-0.250-47%
Return On Equity---1.188-1.1880%-0.179-85%-2.705+128%-2.130+79%
Total Gains Per Share--0.0010.0010%0.014-90%0.001-7%-0.007+613%
Usd Book Value--6235335.7006235335.7000%7047449.200-12%5147038.380+21%8441153.380-26%
Usd Book Value Change Per Share---0.001-0.0010%0.007-116%0.000-75%-0.005+369%
Usd Book Value Per Share--0.0090.0090%0.010-12%0.007+21%0.012-26%
Usd Dividend Per Share--0.0020.0020%0.002-6%0.001+62%0.001+224%
Usd Eps---0.010-0.0100%-0.002-83%-0.009-12%-0.010-1%
Usd Free Cash Flow---4836804.500-4836804.5000%-10834703.000+124%-4753831.940-2%-4007796.430-17%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.015+124%-0.007-2%-0.006-17%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.009+2188%-0.001+37%-0.003+733%
Usd Market Cap9898583.575-133%23096695.00923096695.0090%30638472.971-25%49398645.652-53%76596182.428-70%
Usd Price Per Share0.014-133%0.0320.0320%0.042-25%0.068-53%0.106-70%
Usd Profit---7410128.000-7410128.0000%-1262852.800-83%-6588882.300-11%-7321284.740-1%
Usd Revenue--3760509.5003760509.5000%4843979.800-22%4249604.040-12%8496468.420-56%
Usd Total Gains Per Share--0.0010.0010%0.009-90%0.001-7%-0.005+613%
 EOD+2 -6MRQTTM+0 -0YOY+11 -255Y+14 -2210Y+16 -20

4.2. Fundamental Score

Let's check the fundamental score of Pharmaxis Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.336
Price to Book Ratio (EOD)Between0-11.587
Net Profit Margin (MRQ)Greater than0-1.971
Operating Margin (MRQ)Greater than0-1.932
Quick Ratio (MRQ)Greater than12.424
Current Ratio (MRQ)Greater than12.325
Debt to Asset Ratio (MRQ)Less than10.602
Debt to Equity Ratio (MRQ)Less than11.513
Return on Equity (MRQ)Greater than0.15-1.188
Return on Assets (MRQ)Greater than0.05-0.473
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Pharmaxis Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.359
Ma 20Greater thanMa 500.019
Ma 50Greater thanMa 1000.022
Ma 100Greater thanMa 2000.028
OpenGreater thanClose0.021
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets24,026
Total Liabilities14,467
Total Stockholder Equity9,559
 As reported
Total Liabilities 14,467
Total Stockholder Equity+ 9,559
Total Assets = 24,026

Assets

Total Assets24,026
Total Current Assets18,678
Long-term Assets5,348
Total Current Assets
Cash And Cash Equivalents 9,230
Short-term Investments 2,768
Net Receivables 7,476
Other Current Assets 331
Total Current Assets  (as reported)18,678
Total Current Assets  (calculated)19,805
+/- 1,127
Long-term Assets
Property Plant Equipment 1,843
Intangible Assets 682
Other Assets 2,823
Long-term Assets  (as reported)5,348
Long-term Assets  (calculated)5,348
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,033
Long-term Liabilities6,434
Total Stockholder Equity9,559
Total Current Liabilities
Short-term Debt 2,043
Accounts payable 1,582
Other Current Liabilities 3,469
Total Current Liabilities  (as reported)8,033
Total Current Liabilities  (calculated)7,094
+/- 939
Long-term Liabilities
Other Liabilities 6,434
Long-term Liabilities  (as reported)6,434
Long-term Liabilities  (calculated)6,434
+/-0
Total Stockholder Equity
Common Stock389,699
Retained Earnings -404,453
Other Stockholders Equity 24,313
Total Stockholder Equity (as reported)9,559
Total Stockholder Equity (calculated)9,559
+/-0
Other
Capital Stock389,699
Cash And Equivalents5,978
Cash and Short Term Investments 9,230
Common Stock Shares Outstanding 655,624
Current Deferred Revenue939
Liabilities and Stockholders Equity 24,026
Net Debt -7,187
Net Invested Capital 9,559
Net Tangible Assets 8,877
Net Working Capital 10,645
Property Plant and Equipment Gross 43,264
Short Long Term Debt Total 2,043



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
> Total Assets 
2,144
29,795
28,261
37,937
104,267
82,648
125,049
163,997
140,767
94,572
131,700
112,280
66,747
82,558
65,653
45,434
50,097
52,668
35,416
33,590
25,186
24,026
24,02625,18633,59035,41652,66850,09745,43465,65382,55866,747112,280131,70094,572140,767163,997125,04982,648104,26737,93728,26129,7952,144
   > Total Current Assets 
0
26,831
25,365
34,092
99,311
77,287
118,589
126,466
88,922
46,003
87,274
71,937
40,895
61,540
46,417
28,643
35,984
40,575
24,492
25,309
19,232
18,678
18,67819,23225,30924,49240,57535,98428,64346,41761,54040,89571,93787,27446,00388,922126,466118,58977,28799,31134,09225,36526,8310
       Cash And Cash Equivalents 
751
26,684
25,217
935
97,840
76,182
111,842
124,993
85,787
44,343
81,475
63,943
34,182
54,138
39,209
21,504
31,073
31,124
14,764
18,712
8,937
9,230
9,2308,93718,71214,76431,12431,07321,50439,20954,13834,18263,94381,47544,34385,787124,993111,84276,18297,84093525,21726,684751
       Short-term Investments 
0
0
24,099
32,455
0
0
0
0
0
0
0
0
0
0
35,182
16,479
255
28,333
11,312
8,528
5,996
2,768
2,7685,9968,52811,31228,33325516,47935,182000000000032,45524,09900
       Net Receivables 
0
63
0
106
590
640
2,410
700
2,380
683
4,252
5,770
4,518
5,735
4,849
4,435
2,394
7,191
6,936
2,736
7,642
7,476
7,4767,6422,7366,9367,1912,3944,4354,8495,7354,5185,7704,2526832,3807002,4106405901060630
       Inventory 
0
0
0
0
100
79
96
254
424
864
1,477
2,171
2,150
1,575
2,213
2,570
2,398
2,116
2,630
3,638
2,337
1,641
1,6412,3373,6382,6302,1162,3982,5702,2131,5752,1502,1711,47786442425496791000000
   > Long-term Assets 
0
2,964
2,896
3,846
4,956
5,361
6,460
37,531
51,845
48,569
44,426
40,343
25,852
21,018
19,236
16,791
14,113
12,093
10,924
8,281
5,954
5,348
5,3485,9548,28110,92412,09314,11316,79119,23621,01825,85240,34344,42648,56951,84537,5316,4605,3614,9563,8462,8962,9640
       Property Plant Equipment 
116
1,515
1,474
2,477
3,205
3,521
3,668
32,698
32,537
30,570
27,683
25,115
22,448
19,634
17,793
14,860
12,451
10,264
8,906
6,226
3,212
1,843
1,8433,2126,2268,90610,26412,45114,86017,79319,63422,44825,11527,68330,57032,53732,6983,6683,5213,2052,4771,4741,515116
       Long Term Investments 
0
0
0
0
0
0
1,361
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,361000000
       Intangible Assets 
1,208
1,205
1,162
1,106
1,195
1,239
1,227
1,193
17,702
15,954
14,143
12,429
1,258
363
146
503
446
755
941
1,113
1,024
682
6821,0241,1139417554465031463631,25812,42914,14315,95417,7021,1931,2271,2391,1951,1061,1621,2051,208
       Other Assets 
0
244
260
262
556
601
1,526
3,392
1,606
2,045
2,600
2,799
2,146
1,021
1,297
1,428
1,216
1,074
1,077
942
2,562
2,823
2,8232,5629421,0771,0741,2161,4281,2971,0212,1462,7992,6002,0451,6063,3921,5266015562622602440
> Total Liabilities 
190
604
1,481
2,369
5,379
6,089
5,928
26,306
25,751
23,742
21,897
44,385
48,680
46,237
44,727
41,913
38,979
37,854
33,985
30,745
14,382
14,467
14,46714,38230,74533,98537,85438,97941,91344,72746,23748,68044,38521,89723,74225,75126,3065,9286,0895,3792,3691,481604190
   > Total Current Liabilities 
190
603
1,471
2,342
5,310
5,974
5,740
9,197
9,169
7,743
6,779
8,613
8,282
8,148
11,012
10,521
8,244
8,112
6,825
7,887
6,099
8,033
8,0336,0997,8876,8258,1128,24410,52111,0128,1488,2828,6136,7797,7439,1699,1975,7405,9745,3102,3421,471603190
       Short-term Debt 
0
0
0
32,455
0
0
0
316
371
443
515
594
679
772
864
981
1,098
1,203
1,832
2,032
2,031
2,043
2,0432,0312,0321,8321,2031,09898186477267959451544337131600032,455000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
11,572
10,893
10,122
9,251
8,269
0
0
0
0
0
000008,2699,25110,12210,89311,572000000000000
       Accounts payable 
121
232
245
757
813
2,654
516
1,582
1,086
1,235
922
1,145
1,776
2,700
2,196
3,324
2,130
2,197
1,760
1,240
615
1,582
1,5826151,2401,7602,1972,1303,3242,1962,7001,7761,1459221,2351,0861,5825162,654813757245232121
       Other Current Liabilities 
69
371
1,226
1,585
4,497
3,320
5,224
7,299
7,712
6,065
5,342
6,874
5,827
4,676
7,952
6,216
5,016
1,107
478
1,018
259
3,469
3,4692591,0184781,1075,0166,2167,9524,6765,8276,8745,3426,0657,7127,2995,2243,3204,4971,5851,22637169
   > Long-term Liabilities 
0
1
10
26
69
115
188
17,109
16,582
15,999
15,118
35,772
40,398
38,089
33,715
31,392
30,735
29,742
27,160
22,858
8,283
6,434
6,4348,28322,85827,16029,74230,73531,39233,71538,08940,39835,77215,11815,99916,58217,10918811569261010
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,258
8,270
7,171
5,968
6,322
4,290
2,259
0
02,2594,2906,3225,9687,1718,2709,25800000000000000
       Other Liabilities 
0
1
10
0
0
115
188
3,550
3,424
3,283
2,973
24,212
29,505
27,968
24,457
23,122
23,564
23,774
20,838
18,568
8,631
6,434
6,4348,63118,56820,83823,77423,56423,12224,45727,96829,50524,2122,9733,2833,4243,550188115001010
> Total Stockholder Equity
1,953
29,190
26,780
35,569
98,888
76,559
119,121
137,691
115,016
70,830
109,803
67,895
18,067
36,321
20,926
3,521
11,118
14,814
1,431
2,845
10,804
9,559
9,55910,8042,8451,43114,81411,1183,52120,92636,32118,06767,895109,80370,830115,016137,691119,12176,55998,88835,56926,78029,1901,953
   Common Stock
1,400
32,105
35,695
54,716
134,745
135,108
194,680
245,958
267,050
267,610
344,388
344,623
344,623
344,623
344,623
344,623
344,623
367,301
367,301
371,366
380,440
389,699
389,699380,440371,366367,301367,301344,623344,623344,623344,623344,623344,623344,388267,610267,050245,958194,680135,108134,74554,71635,69532,1051,400
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 
0
-250
-651
-1,187
2,522
4,009
7,439
9,902
12,480
13,492
14,331
15,725
17,715
17,503
18,571
19,512
20,681
21,757
22,317
22,636
23,457
24,313
24,31323,45722,63622,31721,75720,68119,51218,57117,50317,71515,72514,33113,49212,4809,9027,4394,0092,522-1,187-651-2500
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
1
0
7,153
0
0
0
0
0
17,715
-153
18,571
19,512
20,681
21,757
22,317
22,636
23,457
24,313
24,31323,45722,63622,31721,75720,68119,51218,571-15317,715000007,153010000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue5,765
Cost of Revenue-2,706
Gross Profit3,0593,059
 
Operating Income (+$)
Gross Profit3,059
Operating Expense-28,347
Operating Income-11,864-25,288
 
Operating Expense (+$)
Research Development8,713
Selling General Administrative15,523
Selling And Marketing Expenses305
Operating Expense28,34724,541
 
Net Interest Income (+$)
Interest Income387
Interest Expense-223
Other Finance Cost-270
Net Interest Income-106
 
Pretax Income (+$)
Operating Income-11,864
Net Interest Income-106
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,360-25,898
EBIT - interestExpense = -11,360
2,897
-11,137
Interest Expense223
Earnings Before Interest and Taxes (EBIT)-11,137-11,137
Earnings Before Interest and Taxes (EBITDA)-9,289
 
After tax Income (+$)
Income Before Tax-11,360
Tax Provision-0
Net Income From Continuing Ops-11,360-11,360
Net Income-11,360
Net Income Applicable To Common Shares-11,360
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses30,560
Total Other Income/Expenses Net14,034106
 

Technical Analysis of Pharmaxis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmaxis. The general trend of Pharmaxis is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmaxis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharmaxis Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.021 < 0.027 < 0.027.

The bearish price targets are: 0.019 > 0.019 > 0.016.

Tweet this
Pharmaxis Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharmaxis Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharmaxis Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharmaxis Ltd. The current macd is -0.00016381.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pharmaxis price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pharmaxis. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pharmaxis price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Pharmaxis Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPharmaxis Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharmaxis Ltd. The current adx is 28.56.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharmaxis shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Pharmaxis Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharmaxis Ltd. The current sar is 0.01740332.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Pharmaxis Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharmaxis Ltd. The current rsi is 55.36. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Pharmaxis Ltd Daily Relative Strength Index (RSI) ChartPharmaxis Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharmaxis Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmaxis price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pharmaxis Ltd Daily Stochastic Oscillator ChartPharmaxis Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharmaxis Ltd. The current cci is 103.56.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Pharmaxis Ltd Daily Commodity Channel Index (CCI) ChartPharmaxis Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharmaxis Ltd. The current cmo is 31.82.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Pharmaxis Ltd Daily Chande Momentum Oscillator (CMO) ChartPharmaxis Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharmaxis Ltd. The current willr is -16.66666667.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Pharmaxis Ltd Daily Williams %R ChartPharmaxis Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pharmaxis Ltd.

Pharmaxis Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharmaxis Ltd. The current atr is 0.00165681.

Pharmaxis Ltd Daily Average True Range (ATR) ChartPharmaxis Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharmaxis Ltd. The current obv is -24,730,960.

Pharmaxis Ltd Daily On-Balance Volume (OBV) ChartPharmaxis Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharmaxis Ltd. The current mfi is 71.25.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Pharmaxis Ltd Daily Money Flow Index (MFI) ChartPharmaxis Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharmaxis Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-09-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Pharmaxis Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharmaxis Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.359
Ma 20Greater thanMa 500.019
Ma 50Greater thanMa 1000.022
Ma 100Greater thanMa 2000.028
OpenGreater thanClose0.021
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pharmaxis with someone you think should read this too:
  • Are you bullish or bearish on Pharmaxis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmaxis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharmaxis Ltd

I send you an email if I find something interesting about Pharmaxis Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Pharmaxis Ltd.

Receive notifications about Pharmaxis Ltd in your mailbox!